陈祝俊,张拥黎,卢仁泉.血浆氧化型低密度脂蛋白检测在肾细胞癌诊治中的临床意义[J].中国肿瘤,2016,25(5):400-403. |
血浆氧化型低密度脂蛋白检测在肾细胞癌诊治中的临床意义 |
The Clinical Value of Plasma Oxidized Low-density Lipoprotein in Renal Cell Carcinoma |
投稿时间:2015-08-11 |
DOI:10.11735/j.issn.1004-0242.2016.05.A016 |
|
 |
中文关键词: 肾细胞癌 氧化型低密度脂蛋白 酶联免疫吸附试验 |
英文关键词:renal cell carcinoma oxidized low-density lipoprotein enzyme-linked immunosorbent assay |
基金项目:国家自然科学基金(81572552);上海市浦江人才计划项目(14PJD010) |
|
摘要点击次数: 4268 |
全文下载次数: 1229 |
中文摘要: |
摘 要:[ 目的] 评估血浆氧化型低密度脂蛋白(ox-LDL)检测在肾细胞癌诊疗中的临床意义。[方法] 使用ELISA方法测定血浆ox-LDL浓度,研究对象包括84例来自复旦大学附属肿瘤医院的肾细胞癌患者以及对照人群(40名体检健康者)。[结果] 肾细胞癌组血浆ox-LDL含量为9.28(7.93,10.93)ng/ml,显著性高于健康人群血浆ox-LDL含量7.23(6.43,8.00) ng/ml(P<0.05)。 肾细胞癌患者手术治疗后血浆ox-LDL水平较术前有所下降。 血浆ox-LDL与肿瘤大小相关;而恶性程度高的患者血浆ox-LDL较高。[结论] 肾细胞癌患者血浆ox-LDL水平较健康者高,且ox-LDL水平与肿瘤大小和恶性程度密切相关。 |
英文摘要: |
Abstract:[Purpose] To investigate the significance of Plasma Oxidized Low-density Lipoprotein (ox-LDL) in renal cell carcinoma.. [Methods] Plasma ox-LDL in 84 patients with renal cell carcinoma from Fudan University Shanghai Cancer Center and 40 samples from normal individuals as controls were detected by enzyme-linked immunosorbent assay. [Results] Plasma ox-LDL in renal cell carcinoma group[9.28(7.93,10.93)ng/ml ]was higher than that in healthy control group [7.23(6.43,8.00) ng/ml](P<0.05). Plasma ox-LDL level of renal cell carcinoma decreased after surgery,and it correlated with tumor volume in patients with renal cell carcinoma. The level of plasma ox-LDL was elevated with the progression of renal cell carcinoma. [Conclusion] Plasma ox-LDL level in patient with renal cell carcinoma was at a higher level. Furthermore,the ox-LDL level is correlated with tumor volume and tumor malignancy. |
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |